Desalting and Buffer Exchange Market is Growing at a Speedy Double-Digit CAGR of 10.5% During Forecast 2018-2023
Market
Highlights:
The Global
Desalting and Buffer Exchange Market is anticipated to have held a market value
of USD 615.20 million in the year 2017 and is expected to grow at a CAGR
of 10.5% during the forecast period. Desalting and buffer exchange play
a key role in biotechnological companies. Buffer exchange is used to place a
protein solution into a more suitable buffer before applications such as
electrophoresis, ion exchange, affinity chromatography among others. The
increasing demand for monoclonal antibodies, increasing research and
development expenditure by the biopharmaceutical companies, and rising focus on
proteomic and genomic research is anticipated to propel the growth of the
market over the assessment period. On the other hand, the lack of skilled
professionals is excepted to hinder the market growth during the forecast
period.
The global Desalting And Buffer Exchange
Market is currently governed by a large number of market
players. The prominent market players are engaged in strategic collaborations
and mergers to strengthen its market presence. For instance, in August 2017,
Thermo Fisher Scientific acquired Patheon, a contract development and
manufacturing organization (CDMO).
Key Players:
·
Merck KGaA
·
GE Healthcare
·
Sartorius AG
·
Thermo Fisher Scientific
·
Danaher Corporation
·
Agilent Technologies
·
Bio-Rad Laboratories
·
Avantor
·
Repligen Corporation
·
Bio-works Technologies Ab
·
Norgen Biotek Corp
·
Phynexus
Segmentation:
·
The Global Desalting and Buffer Exchange
Market has been segmented into technique, product, and application.
·
On the basis of technique, the global
market has been segmented into filtration, chromatography, and precipitation.
The filtration segment has been further segmented into ultrafiltration and
dialysis. The chromatography segment has been segmented into size-exclusion
chromatography and others.
·
The global desalting and buffer exchange
market, by product, has been segmented into kits, cassettes, filter plates,
spin columns, membrane filters, and others.
·
The market, on the basis of application,
has been segmented into bioprocess applications and diagnostic applications.
Regional
Analysis:
Geographically,
the Americas is expected to dominate the global market owing to the presence of
well-developed healthcare sector, growing demand for biopharmaceuticals,
continuously growing biotechnology sector, increasing research and development
expenditures, and growing research activities in the field of genomics and
proteomics research in the region. Europe is anticipated to hold the second
position in the market owing to the growing number of research and development
activities due to the growth in the R&D expenditure in the region. Asia-Pacific
is anticipated to be the fastest growing region in the global market owing to
the continuously growing biotechnology sector and growing number of
geographical expansions of the prominent market players in the region. The
Middle Eastern and African region is expected to hold the lowest market share
owing to the limited developments in the healthcare sector, especially in the
African region.
Comments
Post a Comment